chr14-22981698-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_032876.6(AJUBA):c.569G>A(p.Gly190Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000805 in 1,366,686 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032876.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AJUBA | NM_032876.6 | c.569G>A | p.Gly190Glu | missense_variant | 1/8 | ENST00000262713.7 | NP_116265.1 | |
AJUBA | NM_001289097.2 | c.569G>A | p.Gly190Glu | missense_variant | 1/2 | NP_001276026.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AJUBA | ENST00000262713.7 | c.569G>A | p.Gly190Glu | missense_variant | 1/8 | 1 | NM_032876.6 | ENSP00000262713.2 | ||
ENSG00000259132 | ENST00000555074.1 | c.49+511G>A | intron_variant | 2 | ENSP00000450856.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000847 AC: 1AN: 118010Hom.: 0 AF XY: 0.0000156 AC XY: 1AN XY: 64214
GnomAD4 exome AF: 0.00000805 AC: 11AN: 1366686Hom.: 0 Cov.: 31 AF XY: 0.0000149 AC XY: 10AN XY: 672544
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 22, 2024 | The c.569G>A (p.G190E) alteration is located in exon 1 (coding exon 1) of the AJUBA gene. This alteration results from a G to A substitution at nucleotide position 569, causing the glycine (G) at amino acid position 190 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at